Community curated by people like you

Bain Capital Ventures stories

Sep 8, 2026

Forus raises $150M at $3B valuation for AI drug access platform

Healthcare automation startup Forus raised $150 million in a Series C round led by Bain Capital Ventures, tripling its valuation to $3 billion in approximately four months. The company uses AI to accelerate patient access to specialty medicines.

Sep 8, 2026·4 sources

00

Top claims

▪Bain Capital Ventures general partner Kevin Zhang stated that the largest companies in medicine have turned to Forus to bring their newest medicines to patients
▪According to Forus CEO Sahir Jaggi, a single prescription can require up to 15 steps across insurance approvals, financial assistance, specialty pharmacy routing, and fulfillment
▪The Series C round brings the total funding raised by Forus, which previously raised $160 million in May 2026, to more than $300 million

Topics

AI startups Venture capital funding